A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care

MLA

Shigeatsu Endo, et al. “A Newly Developed Kit for the Measurement of Urinary Liver-Type Fatty Acid-Binding Protein as a Biomarker for Acute Kidney Injury in Patients with Critical Care.” Journal of Infection and Chemotherapy, vol. 21, Mar. 2015, pp. 165–69. EBSCOhost, https://doi.org/10.1016/j.jiac.2014.10.017.

APA

Shigeatsu Endo, Yoshihiro Inoue, Ryo Sato, Masahiro Kojika, Yasushi Suzuki, & Gaku Takahashi. (2015). A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care. Journal of Infection and Chemotherapy, 21, 165–169. https://doi.org/10.1016/j.jiac.2014.10.017

Chicago

Shigeatsu Endo, Yoshihiro Inoue, Ryo Sato, Masahiro Kojika, Yasushi Suzuki, and Gaku Takahashi. 2015. “A Newly Developed Kit for the Measurement of Urinary Liver-Type Fatty Acid-Binding Protein as a Biomarker for Acute Kidney Injury in Patients with Critical Care.” Journal of Infection and Chemotherapy 21 (March): 165–69. doi:10.1016/j.jiac.2014.10.017.